[The significance of peripheral blood natural killer cell surface CD107a, NKG2D and serum sMICA in patients with extranodal NK/T cell lymphoma, nasal type]
- PMID: 27801344
- DOI: 10.3760/cma.j.issn.0578-1426.2016.11.012
[The significance of peripheral blood natural killer cell surface CD107a, NKG2D and serum sMICA in patients with extranodal NK/T cell lymphoma, nasal type]
Abstract
The expression of CD107a, NKG2D on the surface of natural killer (NK) cells and serum soluble major histocompatibility complex class Ⅰ chain-related A (sMICA) level in patients with extranodal NK/T cell lymphoma, nasal type (ENKL) were detected.We found that CD107a expression was reduced on the surface of NK cells, suggesting impaired NK cell activity in ENKL patients, which may result from decreased NKG2D expression.
Similar articles
-
Augmented serum level of major histocompatibility complex class I-related chain A (MICA) protein and reduced NKG2D expression on NK and T cells in patients with cervical cancer and precursor lesions.BMC Cancer. 2008 Jan 21;8:16. doi: 10.1186/1471-2407-8-16. BMC Cancer. 2008. PMID: 18208618 Free PMC article.
-
The soluble major histocompatibility complex class I-related chain A protein reduced NKG2D expression on natural killer and T cells from patients with prolactinoma and non-secreting pituitary adenoma.J Clin Neurosci. 2010 Feb;17(2):241-7. doi: 10.1016/j.jocn.2009.05.023. Epub 2009 Dec 31. J Clin Neurosci. 2010. PMID: 20045334
-
Increased Concentrations of Circulating Soluble MHC Class I-Related Chain A (sMICA) and sMICB and Modulation of Plasma Membrane MICA Expression: Potential Mechanisms and Correlation With Natural Killer Cell Activity in Systemic Lupus Erythematosus.Front Immunol. 2021 May 3;12:633658. doi: 10.3389/fimmu.2021.633658. eCollection 2021. Front Immunol. 2021. PMID: 34012432 Free PMC article.
-
Generation of soluble NKG2D ligands: proteolytic cleavage, exosome secretion and functional implications.Scand J Immunol. 2013 Aug;78(2):120-9. doi: 10.1111/sji.12072. Scand J Immunol. 2013. PMID: 23679194 Review.
-
Clinical Features and Current Optimal Management of Natural Killer/T-Cell Lymphoma.Hematol Oncol Clin North Am. 2017 Apr;31(2):239-253. doi: 10.1016/j.hoc.2016.11.007. Epub 2017 Jan 30. Hematol Oncol Clin North Am. 2017. PMID: 28340876 Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical